Australian Clinical Labs Ltd
Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers range of services, including molecular cancer, harmony NIPT, genetic carrier screening and other antenatal, cardiac, and commercial drug and alcohol testing services; chemical pathology, haematology, histopathology and cytopathology, serology and microbiology, allergy and immunology, and veter… Read more
Australian Clinical Labs Ltd (ACL) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.416x
Based on the latest financial reports, Australian Clinical Labs Ltd (ACL) has a cash flow conversion efficiency ratio of 0.416x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$62.87 Million) by net assets (AU$151.04 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Australian Clinical Labs Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Australian Clinical Labs Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Australian Clinical Labs Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Australian Clinical Labs Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Priority Technology Holdings Inc Unit
PINK:PRTHU
|
-0.333x |
|
Taiwan Mask Corp
TW:2338
|
0.116x |
|
V-Mart Retail Limited
NSE:VMART
|
0.008x |
|
Guangdong Xiongsu Technology Group Co Ltd
SHE:300599
|
0.001x |
|
Jiangyin Pivot Automotive Products Co. Ltd.
SHE:301181
|
0.011x |
|
Ability Opto-Electronics Technology Co Ltd
TWO:3362
|
-0.008x |
|
Lutian Machinery Co Ltd
SHG:605259
|
-0.005x |
|
dotdigital Group Plc
PINK:DOTDF
|
0.067x |
Annual Cash Flow Conversion Efficiency for Australian Clinical Labs Ltd (2016–2025)
The table below shows the annual cash flow conversion efficiency of Australian Clinical Labs Ltd from 2016 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$171.98 Million | AU$182.80 Million | 1.063x | 0.00% |
| 2024-12-31 | AU$171.98 Million | AU$182.80 Million | 1.063x | +18.39% |
| 2024-06-30 | AU$177.76 Million | AU$159.59 Million | 0.898x | 0.00% |
| 2023-12-31 | AU$177.76 Million | AU$159.59 Million | 0.898x | +7.89% |
| 2023-06-30 | AU$172.67 Million | AU$143.68 Million | 0.832x | 0.00% |
| 2022-12-31 | AU$172.67 Million | AU$143.68 Million | 0.832x | -31.88% |
| 2022-06-30 | AU$232.56 Million | AU$284.09 Million | 1.222x | 0.00% |
| 2021-12-31 | AU$232.56 Million | AU$284.09 Million | 1.222x | -34.97% |
| 2021-06-30 | AU$81.91 Million | AU$153.86 Million | 1.878x | 0.00% |
| 2020-12-31 | AU$81.91 Million | AU$153.86 Million | 1.878x | +27.37% |
| 2020-06-30 | AU$68.99 Million | AU$101.74 Million | 1.475x | 0.00% |
| 2019-12-31 | AU$68.99 Million | AU$101.74 Million | 1.475x | +3536.33% |
| 2019-06-30 | AU$27.42 Million | AU$1.11 Million | 0.041x | 0.00% |
| 2018-12-31 | AU$27.42 Million | AU$1.11 Million | 0.041x | -95.28% |
| 2018-06-30 | AU$5.46 Million | AU$4.69 Million | 0.860x | 0.00% |
| 2017-12-31 | AU$5.46 Million | AU$4.69 Million | 0.860x | +163.80% |
| 2017-06-30 | AU$14.12 Million | AU$4.60 Million | 0.326x | 0.00% |
| 2016-12-31 | AU$14.12 Million | AU$4.60 Million | 0.326x | -- |